Big Pharma Is Pushing Potentially Deadly Alzheimer’s Drugs
The Food and Drug Administration has approved controversial drug treatments for Alzheimer’s disease amid excess deaths, questionable efficacy, and conflicts of interest between regulators, patient advocates, and Big Pharma.